Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth

Neuroscience

Volumn 93, Issue 2, 1999, Pages 783-791

  Hill, J M ^a   Lee, S J ^a   Dibbern Jr , D A ^a   Fridkin, M ^b   Gozes, I ^c   Brenneman, D E ^a  

^a Lab Devmtl Neurbio   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Activity dependent neurotrophic factor; Embryonic growth; Pituitary adenylyl cyclase activating peptide; Receptor; Vasoactive intestinal peptide

Indexed keywords

8 BROMO CYCLIC AMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NEUROPEPTIDE; NEUROTROPHIC FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE DERIVATIVE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTORADIOGRAPHY; BINDING SITE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EMBRYO; EMBRYO GROWTH; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BRAIN; CENTRAL NERVOUS SYSTEM; GUANYLYL IMIDODIPHOSPHATE; MALE; MICE; NEUROPEPTIDES; ORGAN CULTURE TECHNIQUES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032769583     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00155-4     Document Type: Article

References (44)

1. Boudin H., Gruaz-Guyon A., Faure M.P., Forgez P., Lhiaubet A.M., Dennis M., Beaudet A., Rostene W., Pelaprat E. Immunological recognition of different forms of the neurotensin receptor in transfected cells and rat brain. Biochem. J. 305:1995;277-283.
2. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72:1976;248-254.
3. Brenneman D.E., Fitzgerald S., Litzinger M.J. Neuronal survival during electrical blockade is increased by 8-bromo cyclic adenosine 3′,5′ monophosphate. J. Pharmac. exp. Ther. 233:1985;402-408.
4. Brenneman D.E., Gozes I. A femtomolar-acting neuroprotective peptide. J. clin. Invest. 97:1996;2299-2307.
5. Brenneman D.E., Hill J.M., Glazner G.W., Gozes I., Phillips T.W. Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival. Int. J. devl Neurosci. 13:1995;187-200.
6. Brenneman D. E., Hill J. M., Gressens P. and Gozes I. (1990) Neurotrophic action of VIP: from CNS ontogeny to therapeutic strategy. In Proinflammatory and Antiinflammatory Peptides (ed. Said S. I.), pp. 383-408. Marcel Dekker, New York.
7. Brenneman D.E., Neale E.A., Foster G.A., d'Autrement S., Westbrook G.L. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J. Cell Biol. 104:1987;1603-1610.
8. Brown N.A., Fabro S. Quantitation of rat embryonic development in vitro: a morphological scoring system. Teratology. 24:1981;65-78.
9. Burton K. Study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62:1956;315-323.
10. Dibbern D.A., Glazner G.W., Gozes I., Brenneman D.E., Hill J.M. HIV envelope protein gp120 inhibits embryonic growth. J. clin. Invest. 99:1997;2837-2841.
11. Fatatis A., Holtzclaw L.A., Avidor R., Brenneman D.E., Russell J.T. Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with alpha-adrenergic receptors. Proc. natn. Acad. Sci. U.S.A. 91:1994;2036-2040.
12. Festoff B.E., Nelson P.G., Brenneman D.E. Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting, neurotrophic serpin, protease nexin 1. J. Neurobiol. 30:1996;255-266.
13. Gozes I., Bardea A., Reshef A., Zamostiano R., Zhukovsky S., Rubenraut S., Fridkin M., Brenneman D.E. Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. Proc. natn. Acad. Sci. U.S.A. 93:1996;427-432.
14. Gozes I., Lilling G., Glazer R., Ticher A., Ashkenazi I.E., Davidson A., Rubinraut S., Fridkin M., Brenneman D.E. Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. J. Pharmac. exp. Ther. 273:1995;161-167.
15. Gozes I., McCune S.K., Jacobsen L., Warren D., Moody T.W., Fridkin M., Brenneman D.E. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J. Pharmac. exp. Ther. 257:1991;959-966.
16. Gozes I., Reshef A., Salah D., Rubinrout S., Fridkin M. Stearyl-norleucine-VIP, a novel VIP analogue for noninvasive impotence treatment. Endocrinology. 134:1994;2121-2125.
17. Gressens P., Hill J.M., Gozes I., Fridkin M., Brenneman D.E. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature. 362:1993;155-158.
18. Gressens P., Hill J.M., Paindaveine B., Gozes I., Fridkin M., Brenneman D.E. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. J. clin. Invest. 94:1994;2020-2027.
19. Gressens P.B., Paindaveine J.M., Hill P.E., Brenneman D.E. Vasoactive intestinal peptide shortens both G1 and S phases of cell cycle in whole cultured mouse embryos. Eur. J. Neurosci. 10:1998;1734-1742.
20. Gressens P., Marret S., Hill J.M., Brenneman D.E., Gozes I., Fridkin M., Evrard P. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J. clin. Invest. 100:1997;390-397.
21. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., Rawlings S.R., Robberecht P., Said S.I., Sreedharan S.P., Wank J.R., Waschek J.A. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmac. Rev. 50:1998;265-270.
22. Hill J.M., Agoston D.V., Gressens P., McCune S.K. Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: relation to ontogenic events. J. comp. Neurol. 342:1994;186-205.
23. Hill J.M., Gressens P., Brenneman D.E. Growth of the early postimplantation embryo: regulation by high affinity GMP-PNP-insensitive VIP receptors. Ann. N. Y. Acad. Sci. 814:1997;174-180.
24. Hill J.M., Gressens P., Glazner G.W., Brenneman D.E. Floor plate neuroepithelium has binding sites for growth regulator, vasoactive intestinal peptide. Soc. Neurosci. Abstr. 22:1996;1478.
25. Hill J.M., Harris A., Hilton-Clarke D.I. Regional distribution of guanine nucleotide-sensitive and guanine nucleotide-insensitive vasoactive intestinal peptide receptors in rat brain. Neuroscience. 48:1992;925-932.
26. Hill J.M., McCune S.K., Alvero R.J., Glazner G.W., Henins K.A., Stanziale S.F., Keimowitz J.R., Brenneman D.E. Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent. J. clin. Invest. 97:1996;202-208.
27. Inigaki N., Yoshida H., Mizuta M., Mizuno N., Fujii Y., Gonoi T., Miyazaki J., Seino S. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypepide receptor subtype expressed in insulin-secreting cells. Proc. natn. Acad. Sci. U.S.A. 91:1994;2679-2683.
28. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811-819.
29. Jessell T.M., Dodd J. Floor plate-derived signals and the control of neural cell pattern in vertebrates. The Harvey Lecture Series. 86:1992;87-128.
30. Lu N., DiCicco-Bloom E. Pituitary adenylyl cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells. Proc. natn. Acad. Sci. U.S.A. 94:1997;3357-3362.
31. 2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. Fedn Eur. biochem. Socs Lett. 334:1993;3-8.
32. Moody T.W., Taylor D.P., Pert C.B. Effects of guanine nucleotides on CNS neuropeptide receptors. J. supramolec. Struct. 15:1981;153-159.
33. Moroo I., Tatsuno I., Uchida D., Tanaka T., Saito J., Saito Y., Hirai A. Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates mitogen-activated protein kinase (MAPK) in cultured rat astrocytes. Brain Res. 795:1998;191-196.
34. Munro H.N. The determination of nucleic acids. Meth. biochem. Anal. 14:1968;113-176.
35. New D. A. T. (1971) Methods for the culture of postimplantation embryos of rodents. In Methods in Mammalian Embryology (ed. Daniel J. C. Jr), pp. 305-319. Freeman, San Francisco, CA.
36. Olah Z., Lehel Cs., Anderson W.B., Brenneman D.E., Agoston D.V. Subnanomolar concentration of VIP induces the nuclear translocation of protein kinase C in neonatal rat cortical astrocytes. J. Neurosci. Res. 39:1991;355-363.
37. Rawlings S.R., Hezareh M. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endocr. Rev. 17:1996;4-29.
38. Sheward W.J., Lutz E.M., Harmar A.J. The distribution of vasoactive intestinal peptide2 receptor messenger RNA in the rat brain and pituitary gland as assessed by in situ hybridization. Neuroscience. 67:1995;409-418.
39. Sreedharan S.P., Robichon A., Peterson K.E., Goetzl E.J. Cloning and expression of the human vasoactive intestinal peptide receptor. Proc. natn. Acad. Sci. U.S.A. 88:1991;4986-4990.
40. Stella N., Magistretti P.J. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) potentiate the glutamate-evoked release of arachidonic acid from mouse cortial neurons. Evidence for a cAMP-independent mechanism. J. biol. Chem. 271:1996;23,705-23,710.
41. Usdin T.B., Bonner T.I., Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology. 135:1994;2662-2680.
42. Van Maele-Fabry G., Debras J.P., Francois I., Boucau M., Picard J.J. Sera as culture media for 8.5 days whole mouse embryos. Archs Biol. 99:1988;431-453.
43. Van Rampelbergh J., Poloczek P., Francoys I., Delporte C., Winand J., Robberecht P., Waelbroech M. The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins. Biochim. biophys. Acta. 1357:1997;249-255.
44. Vertongen P., Schiffmann S.N., Gourlet P., Robberecht P. Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain. Peptides. 18:1997;1547-1554.